SBFM Sunshine Biopharma, Inc.

NASDAQ
$0.84

Sunshine Biopharma, Inc. (SBFM) is expected to report earnings on November 12, 2026, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of -30.4% since its last earnings release on August 13, 2026.

Sunshine Biopharma Reported Earnings
Thursday, August 13, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.18

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Sunshine Biopharma, Inc.

Sunshine Biopharma Inc. is a pharmaceutical company. It focused on the research, development and commercialization of oncology and antiviral drugs. Sunshine Biopharma Inc. is based in MONTREAL.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.